B25 Cytomegaloviral disease

Name of the Condition

• Cytomegaloviral disease

Summary

Cytomegaloviral disease is an infection caused by the cytomegalovirus (CMV), a member of the Herpesviridae family. It can affect various organ systems and may present as localized or systemic disease, with severity depending on the individual's immune status. The condition ranges from asymptomatic infection to severe, life-threatening illness in immunocompromised patients.

Causes

The disease is caused by the cytomegalovirus (CMV), which is transmitted through direct contact with infected bodily fluids (e.g., saliva, urine, blood, or breast milk). Primary infection occurs when the virus enters the body, and reactivation can happen in individuals with weakened immune systems. Congenital transmission from mother to fetus is also possible during pregnancy.

Risk Factors

• Immunocompromised states, including HIV/AIDS, organ transplantation, or immunosuppressive therapy.
• Neonates and infants, particularly those born to mothers with primary CMV infection during pregnancy.
• Close contact with young children or individuals shedding the virus (e.g., in daycare settings).
• Advanced age, which may be associated with declining immune function.

Symptoms

• Fatigue and malaise.
• Fever.
• Swollen lymph nodes.
• Hepatitis (liver inflammation) with abdominal pain or jaundice.
• Pneumonia (lung infection) with cough or shortness of breath.
• Gastrointestinal symptoms (e.g., nausea, diarrhea).
• Neurological symptoms (e.g., encephalitis, seizures) in severe cases.
• Retinitis (eye infection) with vision changes.

Diagnosis

Diagnosis involves laboratory testing to detect CMV. Blood tests may identify viral DNA, antigens, or antibodies. Tissue samples (e.g., from biopsy) can confirm viral presence in affected organs. Imaging (e.g., X-rays, CT scans) or endoscopic procedures may be used to evaluate organ involvement. Clinical correlation with symptoms and risk factors is essential.

Treatment Options

• Antiviral medications (e.g., ganciclovir, valganciclovir) for severe or systemic disease, particularly in immunocompromised patients.
• Supportive care (e.g., rest, hydration, pain management) for mild or asymptomatic cases.
• Monitoring for organ-specific complications (e.g., liver or lung involvement).
• Preventive strategies (e.g., antiviral prophylaxis) in high-risk groups like transplant recipients.

Prognosis and Follow-Up

Prognosis varies by immune status: healthy individuals often recover fully, while immunocompromised patients may experience prolonged or recurrent disease. Follow-up includes monitoring for symptom resolution, organ function, and viral load. Regular assessments are critical for those with chronic or severe infections to detect relapse or complications.

Complications

• Organ damage (e.g., liver failure, pneumonitis, retinal scarring).
• Neurological sequelae (e.g., hearing loss, developmental delays in congenital cases).
• Graft rejection or failure in transplant recipients.
• Increased susceptibility to other infections due to immune suppression.

Lifestyle & Prevention

• Practice good hygiene (e.g., handwashing) to reduce transmission risk.
• Avoid sharing personal items (e.g., utensils, towels) with infected individuals.
• Pregnant individuals should avoid contact with young children or those with active CMV.
• Immunocompromised patients should discuss preventive measures (e.g., antiviral prophylaxis) with their healthcare provider.

When to Seek Professional Help

Seek medical attention if you experience persistent fever, unexplained fatigue, jaundice, difficulty breathing, or neurological symptoms (e.g., confusion, seizures). Immunocompromised individuals or pregnant people with suspected exposure should consult a healthcare provider promptly.

Tips for Medical Coders

Document the specific manifestation (e.g., hepatitis, pneumonitis) when reported, as this may influence coding specificity. Note the patient's immune status (e.g., HIV, transplant) if relevant, as it can impact code assignment. Ensure documentation supports the clinical scenario to align with ICD-10-CM guidelines for B25.